| Date | Title | Description |
| 30.06.2025 | Apple Tree Partners Statement Regarding LP Litigation | Updated June 30, 2025
On May 30, 2025, Apple Tree Partners (ATP)’s fund ATP Life Science Ventures initiated litigation by filing a Complaint against its controlling limited partners (LPs) Rigmora Biotech Investor One LP and Rigmora Biotech ... |
| 11.06.2025 | Deep Apple Therapeutics Announces Collaboration with Novo Nordisk to Discover and Develop Oral Therapeutics for Cardiometabolic Diseases | Partnership aims to develop first-in-class, small molecule therapeutics directed at a novel non-incretin GPCR target for cardiometabolic diseases
Deep Apple is eligible to receive up to $812 million, including an upfront payment, research c... |
| 20.12.2023 | Deep Apple Therapeutics Launches With $52 Million In Funding | Apple Tree Partners (ATP) – a leader in life sciences venture capital – recently announced $52 million in Series A funding for its portfolio company Deep Apple Therapeutics, created and incubated by ATP to rapidly discover novel small molec... |
| 15.12.2023 | Deep Apple Therapeutics Raises $52M in Series A Funding | Deep Apple Therapeutics, a San Francisco, CA-based company that discovers novel small molecule therapeutics for high-value targets through virtual screening of AI-generated virtual libraries, raised $52M in Series A funding.
The round was l... |
| 14.12.2023 | Apple Tree Partners Unveils Deep Apple Therapeutics to Dramatically Accelerate Drug Discovery with Structure-Based, Ultra-Large Library Virtual Screening and Deep Learning Models | Conducting entirely virtual screens of multi-billion molecule virtual libraries, Deep Apple can quickly identify hits that promote specific signaling in GPCRs and other target classes |
| 14.12.2023 | Apple Tree Partners Unveils Deep Apple Therapeutics to Dramatically Accelerate Drug Discovery with Structure-Based, Ultra-Large Library Virtual Screening and Deep Learning Models | Conducting entirely virtual screens of multi-billion molecule virtual libraries, Deep Apple can quickly identify hits that promote specific signaling in GPCRs and other target classes
San Francisco-based company created by ATP with academi... |
